Condition

Idiopathic CD4 Lymphopenia clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Testing a new drug to increase CD4 T cells in patients with low immune cell counts

  This study is testing a new drug to see if it can safely boost immune cell levels in people with low CD4 T cell counts due to idiopathic CD4 lymphopenia.

  Recruiting Phase 1/2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT05600920

• Evaluating the safety of belimumab for people with low CD4 cell counts and autoantibodies

  This study is testing if belimumab is safe for adults with low CD4 cell counts and autoantibodies to see if it could be a new treatment option for their condition.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT04097561

Related topics

Quick answers

How many Idiopathic CD4 Lymphopenia clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →